Brief: Akari Therapeutics To Change ADS Ratio To 1 ADS Per 80,000 Ordinary Shares
17/03/2026 20:36
March 17 (Reuters) - Akari Therapeutics PLC AKTX.O: AKARI THERAPEUTICS PLC - TO CHANGE ADS RATIO TO 1 ADS PER 80,000 ORDINARY SHARES AKARI THERAPEUTICS PLC - ADS RATIO CHANGE EXPECTED TO BE EFFECTIVE ON MARCH 31, 2026 Source text: ID:nGNX6FxCNl Further company coverage: AKTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics